Wiadomosci lekarskie (Warsaw, Poland : 1960) · 2024
Histopathological, immunohistochemical and physiological study for the hepatoprotective effect of melatonin against inhrifampicin-induced hepatotoxicity in mice model.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Al-Rehemi Siham Mahmood, Dosh Rasha Hatem, Frayyeh Maha Jamal, Al Mudhafar Rihab Hameed, Abdulkadhim Hussein
Аннотация
OBJECTIVE: Aim: The purpose of this study is to assess the hepatoprotective ef f ect of melatonin against isoniazid (INH) and rifampicin (RMP) induced hepatotoxicity in albino mice.
PATIENTS AND METHODS: Materials and Methods: Adult male mice were divided into four groups: saline, INH-RMP, INH-RMP+MT and MT were administered for 21 days. Biochemical analyses were performed for the determination of ALT, AST. Histopathological changes in the liver and Immunohistochemical assessment to determine the expression of Caspace3 were also examined.
RESULTS: Results: Biochemical analysis revealed signif i cant increases in serum ALT and AST in INH-RMP group. Histopathological fi ndings demonstrated severe liver damage in INH-RMP group as compared with control group. In contrast, treatment of mice with melatonin (MT) markedly mitigated the liver injury. Immunohistochemical fi ndings demonstrated apoptotic marker caspace3 signif i cantly higher in INH-RMP group as compared with control group.
CONCLUSION: Conclusions: Experimental fi ndings highlight the potential benef i ts of melatonin in this model, prompting speculation on its potential application in human therapy.
PATIENTS AND METHODS: Materials and Methods: Adult male mice were divided into four groups: saline, INH-RMP, INH-RMP+MT and MT were administered for 21 days. Biochemical analyses were performed for the determination of ALT, AST. Histopathological changes in the liver and Immunohistochemical assessment to determine the expression of Caspace3 were also examined.
RESULTS: Results: Biochemical analysis revealed signif i cant increases in serum ALT and AST in INH-RMP group. Histopathological fi ndings demonstrated severe liver damage in INH-RMP group as compared with control group. In contrast, treatment of mice with melatonin (MT) markedly mitigated the liver injury. Immunohistochemical fi ndings demonstrated apoptotic marker caspace3 signif i cantly higher in INH-RMP group as compared with control group.
CONCLUSION: Conclusions: Experimental fi ndings highlight the potential benef i ts of melatonin in this model, prompting speculation on its potential application in human therapy.